Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with chronic alcoholic liver disease

J. Fehér, I. Láng, K. Nékám, G. Csomós, G. Müzes, G. Deák

Research output: Article

18 Citations (Scopus)

Abstract

The in vitro and in vivo effects of the naturally occuring Ravolignan hepatoprotective agent silibinin† on the expression and activity of superoxide dismutase (SOD) enzyme were studied in lymphocytes from patients with chronic alcoholic liver disease. In vitro incubation with silibinin in a concentration corresponding to the usual therapeutic dosage markedly increased the SOD - expression of lymphocytes as measured by Row-cytofluorimetry following staining with monoclonal anti-Cu, Zn-SOD - antibody and FITC-conjugated anti-mouse Ig. In vivo treatment with the drug restored the originally low SOD activity of the patients' lymphocytes. These data indirectly suggest that antioxidant activity might be one of the important factors in the hepatoprotective action of silibinin.

Original languageEnglish
Pages (from-to)373-377
Number of pages5
JournalFree radical research
Volume3
Issue number6
DOIs
Publication statusPublished - jan. 1 1987

ASJC Scopus subject areas

  • Biochemistry

Fingerprint Dive into the research topics of 'Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with chronic alcoholic liver disease'. Together they form a unique fingerprint.

  • Cite this